The injection produces slightly higher average weight loss overall, but Wegovy tablets show a higher proportion of patients losing 20% or more
Shu Q, Chen L, Wu S, Li J, Liu J, Xiao L, et al
These medications rely on prolonged use to maintain results, leaving many individuals grappling with dependency, side effects, or diminishing effectiveness over time
Retatrutide is currently in Phase 3 clinical trials and is not yet approved by Health Canada or the FDA for obesity treatment
Pharmacotherapies include: These agents act through complementary mechanisms to preserve renal function
GLP-1 receptor agonists are a class of medications that mimic a natural hormone in your body that regulates appetite and blood sugar